Clinical Trials Browser

Completed × OTHER × Interleukin-18 × Clear all

NCT01768338 2023-02-10

Recombinant Human IL-18 and Ofatumumab After PBSCT for Lymphoma

Phase 1 Completed

Lymphoma, Non-Hodgkin